S.Africa tackles drugs patent reform

September 9, 2013

South Africa's government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs.

If accepted, the reforms will facilitate the production of cheaper, generic medicines, according to Doctors Without Borders (MSF) and local AIDS-activist group Treatment Action Campaign.

The policies "set the stage for changes that promise to increase competition in the and lower the price of medicines in South Africa," the group said in a statement.

South Africa's current laws allow firms to renew patents indefinitely by changing minute elements in a medicine's composition.

"This allows companies to extend the life of their monopolies, block competition from , and charge inflated prices for medicines in both the public and private sector," said the rights groups.

The new patent policies will allow the production of and grant over five million South Africans living with AIDS or multi drug-resistant (MDR) tuberculosis access to treatments.

The country's powerful drug-makers treated the draft with caution.

"We would support anything that would increase IP (intellectual property) protection," said Val Beaumont, who heads the Innovative Pharmaceutical Association of South Africa.

The Department of Trade and Industry invited public consultation on the text until October 4, though the policy could take years to finalise.

According to the document, South Africa does not have a written national IP policy which has led to a fragmented approach to such matters.

Explore further: Bayer mulls challenge to India cancer drug ruling

Related Stories

Bayer mulls challenge to India cancer drug ruling

March 13, 2012

Bayer AG said Tuesday it was mulling ways to challenge a ground-breaking Indian ruling allowing a local firm to produce a vastly cheaper copy of a cancer drug made by the German pharmaceutical giant.

India's top court to deliver Novartis judgment

March 31, 2013

India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they ...

Patents making new AIDS drugs expensive, MSF says

July 2, 2013

New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.

Activists warn trade pact will keep out generics (Update)

July 3, 2013

A free trade pact being negotiated by the U.S. and 11 Asia-Pacific nations will impose aggressive intellectual property rules that could restrict access to affordable medicines in developing nations, health activists warned ...

Recommended for you

Re-framing the placebo effect and informed consent

October 29, 2015

(Medical Xpress)—Imagine that your doctor knows from evidence-based studies that if he tells you about certain, small side-effects to a particular drug, you are significantly more likely to experience that side effect than ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.